substance p has been researched along with fluorouracil in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Denny, TN; Donnelly, RJ; Gascón, P; Ge, H; Goldstein, KR; Qian, J; Rameshwar, P; Zhu, G | 1 |
| Arakawa, K; Horie, S; Kato, S; Matsumoto, K; Nakajima, T; Narita, M; Sagara, A; Sakai, H; Tashima, K | 1 |
| Li, S; Qu, D; Tian, H; Wu, J; Zhou, Y; Zhu, WH | 1 |
3 other study(ies) available for substance p and fluorouracil
| Article | Year |
|---|---|
The dynamics of bone marrow stromal cells in the proliferation of multipotent hematopoietic progenitors by substance P: an understanding of the effects of a neurotransmitter on the differentiating hematopoietic stem cell.
Topics: Cell Differentiation; Cell Division; Cells, Cultured; Drug Synergism; Fluorouracil; Gene Expression; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Interleukin-1; Interleukin-3; Interleukin-6; Macrophages; Neuroimmunomodulation; Receptors, Interleukin-1; Receptors, Neurokinin-1; Receptors, Neurokinin-2; RNA, Messenger; Stem Cell Factor; Stromal Cells; Substance P | 2001 |
Increased expression of 5-HT3 and NK 1 receptors in 5-fluorouracil-induced mucositis in mouse jejunum.
Topics: Animals; Autocrine Communication; Disease Models, Animal; Fluorouracil; Jejunal Diseases; Macrophages; Male; Mast Cells; Mice; Mice, Inbred C57BL; Mucositis; Paracrine Communication; Receptors, Neurokinin-1; Receptors, Serotonin, 5-HT3; Substance P; Up-Regulation | 2013 |
Real-time near-infrared bioimaging of a receptor-targeted cytotoxic dendritic theranostic agent.
Topics: A549 Cells; Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Computer Systems; Cyclobutanes; Dendrimers; Female; Fluorescent Dyes; Fluorouracil; Humans; Infrared Rays; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Targeted Therapy; Nanocapsules; Nanoconjugates; Neoplasms, Experimental; Phenols; Receptors, Neurokinin-1; Substance P; Theranostic Nanomedicine; Treatment Outcome | 2017 |